GlassScriptPhysician profile
John W Wheatley
NPI 1962458737
$1,896.47
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $184 · 2020: $112 · 2021: $411 · 2022: $463 · 2023: $711 · 2024: $15.69.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $727.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $726.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $347.36 | 2019-2023 | Rybelsus, Ozempic |
| Abbvie INC. | $276.22 | 2021-2024 | Vraylar, Ubrelvy |
| Astrazeneca Pharmaceuticals LP | $221.42 | 2021-2023 | Breztri, Farxiga |
| Pfizer INC. | $195.16 | 2019-2023 | |
| Glaxosmithkline, LLC. | $155.25 | 2021-2023 | Trelegy Ellipta, Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $126.28 | 2020-2023 | Tradjenta, Jardiance |
| Amgen INC. | $110.43 | 2019-2023 | Repatha |
| Novartis Pharmaceuticals Corporation | $81.52 | 2019-2022 | |
| Amarin Pharma, INC. | $63.47 | 2020-2021 | |
| Esperion Therapeutics, INC. | $51.29 | 2021 | |
| Allergan, INC. | $38.58 | 2019-2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $31.69 | 2022 | |
| Sanofi-Aventis U.S. LLC | $26.73 | 2022 | |
| Si-Bone, INC. | $19.25 | 2021 | |
| Hologic Sales and Service, LLC | $16.45 | 2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $15.65 | 2019 | |
| Abbott Laboratories | $14.85 | 2023 | Freestyle Libre |
| Boston Scientific Corporation | $14.61 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.49 | 2023 | |
| Exact Sciences Corporation | $14.40 | 2023 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $12.91 | 2019 | |
| Mylan Specialty L.P. | $12.58 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.44 | 2019 | |
| Lilly USA, LLC | $12.36 | 2021 | |
| Janssen Pharmaceuticals, INC | $11.08 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Wheatley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.